Loading...
Demant A/S
WILYY•PNK
HealthcareMedical - Devices
$19.76
$-0.44(-2.18%)
Demant A/S (WILYY) Financial Performance & Statements
Review Demant A/S’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-0.11%
↓ 0.11%
Operating Income Growth
6.17%
↑ 6.17%
Net Income Growth
32.98%
↑ 32.98%
Operating Cash Flow Growth
-4.45%
↓ 4.45%
Operating Margin
18.94%
↑ 18.94%
Gross Margin
75.51%
↑ 75.51%
Net Profit Margin
10.76%
↑ 10.76%
ROE
25.40%
↑ 25.40%
ROIC
16.12%
↑ 16.12%
Demant A/S (WILYY) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Demant A/S stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $11.33B | $11.09B | $11.35B | $5.64B |
| Cost of Revenue | $2.75B | $2.58B | $2.92B | $1.46B |
| Gross Profit | $8.58B | $8.51B | $8.43B | $4.19B |
| Gross Profit Ratio | $0.76 | $0.77 | $0.74 | $0.74 |
| R&D Expenses | $661.00M | $733.00M | $704.00M | $352.00M |
| SG&A Expenses | $5.68B | $5.74B | $5.67B | $2.77B |
| Operating Expenses | $6.34B | $6.32B | $6.37B | $3.26B |
| Total Costs & Expenses | -$9.09B | $8.89B | $9.29B | $4.72B |
| Interest Income | $60.00M | $106.00M | $54.00M | $55.00M |
| Interest Expense | $462.00M | $926.00M | $449.00M | $0.00 |
| Depreciation & Amortization | $730.00M | $313.50M | $156.75M | $138.00M |
| EBITDA | $3.06B | $2.36B | $1.22B | $1.20B |
| EBITDA Ratio | $0.27 | $0.21 | $0.11 | $0.21 |
| Operating Income | $2.24B | $2.19B | $2.06B | $1.06B |
| Operating Income Ratio | $0.20 | $0.20 | $0.18 | $0.19 |
| Other Income/Expenses (Net) | -$377.00M | -$410.00M | -$197.50M | -$189.00M |
| Income Before Tax | $1.87B | $1.78B | $1.71B | $869.50M |
| Income Before Tax Ratio | $0.16 | $0.16 | $0.15 | $0.15 |
| Income Tax Expense | $396.00M | $428.00M | $442.00M | $221.00M |
| Net Income | $1.18B | $1.20B | $1.21B | $647.50M |
| Net Income Ratio | $0.10 | $0.11 | $0.11 | $0.11 |
| EPS | $5.53 | $6.18 | $5.44 | $2.90 |
| Diluted EPS | $5.53 | $6.18 | $5.44 | $2.90 |
| Weighted Avg Shares Outstanding | $213.01M | $218.97M | $223.13M | $223.09M |
| Weighted Avg Shares Outstanding (Diluted) | $213.01M | $218.97M | $223.13M | $223.09M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan